25 XP   0   0   10

Cassava Sciences Inc
Buy, Hold or Sell?

Let's analyse Cassava Sciences Inc together

PenkeI guess you are interested in Cassava Sciences Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Cassava Sciences Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Cassava Sciences Inc

I send you an email if I find something interesting about Cassava Sciences Inc.

Quick analysis of Cassava Sciences Inc (30 sec.)










What can you expect buying and holding a share of Cassava Sciences Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$3.18
Expected worth in 1 year
$1.10
How sure are you?
17.5%

+ What do you gain per year?

Total Gains per Share
$-2.08
Return On Investment
-10.0%

For what price can you sell your share?

Current Price per Share
$20.74
Expected price per share
$18.18 - $27.18
How sure are you?
50%

1. Valuation of Cassava Sciences Inc (5 min.)




Live pricePrice per Share (EOD)

$20.74

Intrinsic Value Per Share

$-34.91 - $-13.47

Total Value Per Share

$-31.73 - $-10.29

2. Growth of Cassava Sciences Inc (5 min.)




Is Cassava Sciences Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$137.4m$220.4m-$51.4m-30.4%

How much money is Cassava Sciences Inc making?

Current yearPrevious yearGrowGrow %
Making money-$23.6m-$18m-$5.6m-23.7%
Net Profit Margin-222.7%240,708.3%--

How much money comes from the company's main activities?

3. Financial Health of Cassava Sciences Inc (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#323 / 1010

Most Revenue
#538 / 1010

Most Profit
#725 / 1010

Most Efficient
#646 / 1010

What can you expect buying and holding a share of Cassava Sciences Inc? (5 min.)

Welcome investor! Cassava Sciences Inc's management wants to use your money to grow the business. In return you get a share of Cassava Sciences Inc.

What can you expect buying and holding a share of Cassava Sciences Inc?

First you should know what it really means to hold a share of Cassava Sciences Inc. And how you can make/lose money.

Speculation

The Price per Share of Cassava Sciences Inc is $20.74. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Cassava Sciences Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Cassava Sciences Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $3.18. Based on the TTM, the Book Value Change Per Share is $-0.52 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.15 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Cassava Sciences Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.48-2.3%-0.56-2.7%-0.44-2.1%-0.25-1.2%-0.16-0.8%
Usd Book Value Change Per Share-0.41-2.0%-0.52-2.5%-0.15-0.7%0.140.7%0.050.2%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.41-2.0%-0.52-2.5%-0.15-0.7%0.140.7%0.050.2%
Usd Price Per Share22.51-21.95-34.16-24.75-13.74-
Price to Earnings Ratio-11.63--9.86--19.41--40.01--25.38-
Price-to-Total Gains Ratio-55.16--43.05--52.03--215.12--119.90-
Price to Book Ratio7.08-5.69-6.76-7.16-6.86-
Price-to-Total Gains Ratio-55.16--43.05--52.03--215.12--119.90-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share20.74
Number of shares48
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.520.14
Usd Total Gains Per Share-0.520.14
Gains per Quarter (48 shares)-24.996.54
Gains per Year (48 shares)-99.9726.16
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-100-11002616
20-200-21005242
30-300-31007868
40-400-410010594
50-500-5100131120
60-600-6100157146
70-700-7100183172
80-800-8100209198
90-900-9100235224
100-1000-10100262250

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.020.00.00.0%0.040.00.00.0%11.085.00.011.5%
Book Value Change Per Share0.04.00.00.0%2.010.00.016.7%5.015.00.025.0%7.033.00.017.5%37.058.01.038.5%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.040.00.0%2.00.094.02.1%
Total Gains per Share0.04.00.00.0%2.010.00.016.7%5.015.00.025.0%7.033.00.017.5%39.056.01.040.6%

Fundamentals of Cassava Sciences Inc

About Cassava Sciences Inc

Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2 clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's disease. The company was formerly known as Pain Therapeutics, Inc. and changed its name to Cassava Sciences, Inc. in March 2019. Cassava Sciences, Inc. was incorporated in 1998 and is based in Austin, Texas.

Fundamental data was last updated by Penke on 2024-04-12 17:52:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Cassava Sciences Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Cassava Sciences Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Cassava Sciences Inc to the Biotechnology industry mean.
  • A Net Profit Margin of -890.9% means that $-8.91 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Cassava Sciences Inc:

  • The MRQ is -890.9%. The company is making a huge loss. -2
  • The TTM is -222.7%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-890.9%TTM-222.7%-668.2%
TTM-222.7%YOY240,708.3%-240,931.1%
TTM-222.7%5Y402,397.1%-402,619.9%
5Y402,397.1%10Y201,198.6%+201,198.6%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-890.9%-200.1%-690.8%
TTM-222.7%-216.8%-5.9%
YOY240,708.3%-288.3%+240,996.6%
5Y402,397.1%-449.1%+402,846.2%
10Y201,198.6%-605.5%+201,804.1%
1.1.2. Return on Assets

Shows how efficient Cassava Sciences Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Cassava Sciences Inc to the Biotechnology industry mean.
  • -13.8% Return on Assets means that Cassava Sciences Inc generated $-0.14 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Cassava Sciences Inc:

  • The MRQ is -13.8%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -13.0%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-13.8%TTM-13.0%-0.8%
TTM-13.0%YOY-7.9%-5.0%
TTM-13.0%5Y-6.8%-6.2%
5Y-6.8%10Y-10.2%+3.4%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-13.8%-13.3%-0.5%
TTM-13.0%-12.8%-0.2%
YOY-7.9%-11.7%+3.8%
5Y-6.8%-13.9%+7.1%
10Y-10.2%-15.7%+5.5%
1.1.3. Return on Equity

Shows how efficient Cassava Sciences Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Cassava Sciences Inc to the Biotechnology industry mean.
  • -15.2% Return on Equity means Cassava Sciences Inc generated $-0.15 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Cassava Sciences Inc:

  • The MRQ is -15.2%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -14.3%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-15.2%TTM-14.3%-1.0%
TTM-14.3%YOY-8.2%-6.0%
TTM-14.3%5Y-7.2%-7.0%
5Y-7.2%10Y-10.9%+3.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-15.2%-16.9%+1.7%
TTM-14.3%-16.1%+1.8%
YOY-8.2%-15.1%+6.9%
5Y-7.2%-19.3%+12.1%
10Y-10.9%-20.2%+9.3%

1.2. Operating Efficiency of Cassava Sciences Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Cassava Sciences Inc is operating .

  • Measures how much profit Cassava Sciences Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Cassava Sciences Inc to the Biotechnology industry mean.
  • An Operating Margin of -970.6% means the company generated $-9.71  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Cassava Sciences Inc:

  • The MRQ is -970.6%. The company is operating very inefficient. -2
  • The TTM is -242.6%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-970.6%TTM-242.6%-727.9%
TTM-242.6%YOY296,194.4%-296,437.1%
TTM-242.6%5Y428,115.4%-428,358.0%
5Y428,115.4%10Y214,057.7%+214,057.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-970.6%-296.2%-674.4%
TTM-242.6%-232.5%-10.1%
YOY296,194.4%-298.2%+296,492.6%
5Y428,115.4%-492.1%+428,607.5%
10Y214,057.7%-632.4%+214,690.1%
1.2.2. Operating Ratio

Measures how efficient Cassava Sciences Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 9.71 means that the operating costs are $9.71 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Cassava Sciences Inc:

  • The MRQ is 9.706. The company is inefficient in keeping operating costs low. -1
  • The TTM is 2.426. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ9.706TTM2.426+7.279
TTM2.426YOY-2,961.944+2,964.371
TTM2.4265Y-4,202.904+4,205.330
5Y-4,202.90410Y-2,101.452-2,101.452
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ9.7063.231+6.475
TTM2.4263.310-0.884
YOY-2,961.9443.890-2,965.834
5Y-4,202.9045.739-4,208.643
10Y-2,101.4527.876-2,109.328

1.3. Liquidity of Cassava Sciences Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Cassava Sciences Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 9.13 means the company has $9.13 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Cassava Sciences Inc:

  • The MRQ is 9.132. The company is very able to pay all its short-term debts. +2
  • The TTM is 10.382. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ9.132TTM10.382-1.250
TTM10.382YOY27.027-16.644
TTM10.3825Y28.412-18.030
5Y28.41210Y24.248+4.164
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ9.1323.890+5.242
TTM10.3824.173+6.209
YOY27.0275.344+21.683
5Y28.4126.126+22.286
10Y24.2486.448+17.800
1.3.2. Quick Ratio

Measures if Cassava Sciences Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Cassava Sciences Inc to the Biotechnology industry mean.
  • A Quick Ratio of 8.60 means the company can pay off $8.60 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Cassava Sciences Inc:

  • The MRQ is 8.601. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 9.954. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ8.601TTM9.954-1.352
TTM9.954YOY25.746-15.792
TTM9.9545Y27.811-17.858
5Y27.81110Y24.104+3.707
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ8.6013.514+5.087
TTM9.9543.998+5.956
YOY25.7465.380+20.366
5Y27.8116.105+21.706
10Y24.1046.404+17.700

1.4. Solvency of Cassava Sciences Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Cassava Sciences Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Cassava Sciences Inc to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.09 means that Cassava Sciences Inc assets are financed with 9.4% credit (debt) and the remaining percentage (100% - 9.4%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Cassava Sciences Inc:

  • The MRQ is 0.094. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.087. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.094TTM0.087+0.006
TTM0.087YOY0.035+0.052
TTM0.0875Y0.049+0.039
5Y0.04910Y0.056-0.008
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0940.339-0.245
TTM0.0870.336-0.249
YOY0.0350.271-0.236
5Y0.0490.366-0.317
10Y0.0560.389-0.333
1.4.2. Debt to Equity Ratio

Measures if Cassava Sciences Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Cassava Sciences Inc to the Biotechnology industry mean.
  • A Debt to Equity ratio of 10.3% means that company has $0.10 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Cassava Sciences Inc:

  • The MRQ is 0.103. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.096. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.103TTM0.096+0.007
TTM0.096YOY0.037+0.060
TTM0.0965Y0.052+0.044
5Y0.05210Y0.061-0.009
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1030.388-0.285
TTM0.0960.402-0.306
YOY0.0370.335-0.298
5Y0.0520.426-0.374
10Y0.0610.461-0.400

2. Market Valuation of Cassava Sciences Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Cassava Sciences Inc generates.

  • Above 15 is considered overpriced but always compare Cassava Sciences Inc to the Biotechnology industry mean.
  • A PE ratio of -11.63 means the investor is paying $-11.63 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Cassava Sciences Inc:

  • The EOD is -10.719. Based on the earnings, the company is expensive. -2
  • The MRQ is -11.634. Based on the earnings, the company is expensive. -2
  • The TTM is -9.861. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-10.719MRQ-11.634+0.915
MRQ-11.634TTM-9.861-1.773
TTM-9.861YOY-19.413+9.552
TTM-9.8615Y-40.007+30.146
5Y-40.00710Y-25.379-14.628
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-10.719-2.264-8.455
MRQ-11.634-2.629-9.005
TTM-9.861-2.680-7.181
YOY-19.413-4.145-15.268
5Y-40.007-6.257-33.750
10Y-25.379-6.254-19.125
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Cassava Sciences Inc:

  • The EOD is -10.029. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -10.885. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -12.532. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-10.029MRQ-10.885+0.856
MRQ-10.885TTM-12.532+1.647
TTM-12.532YOY-19.015+6.483
TTM-12.5325Y-46.684+34.152
5Y-46.68410Y-30.844-15.840
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-10.029-2.973-7.056
MRQ-10.885-3.333-7.552
TTM-12.532-3.553-8.979
YOY-19.015-5.605-13.410
5Y-46.684-8.376-38.308
10Y-30.844-8.865-21.979
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Cassava Sciences Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 7.08 means the investor is paying $7.08 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Cassava Sciences Inc:

  • The EOD is 6.525. Based on the equity, the company is overpriced. -1
  • The MRQ is 7.081. Based on the equity, the company is overpriced. -1
  • The TTM is 5.686. Based on the equity, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD6.525MRQ7.081-0.557
MRQ7.081TTM5.686+1.395
TTM5.686YOY6.765-1.078
TTM5.6865Y7.164-1.477
5Y7.16410Y6.861+0.303
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD6.5251.896+4.629
MRQ7.0812.115+4.966
TTM5.6862.093+3.593
YOY6.7652.884+3.881
5Y7.1643.542+3.622
10Y6.8613.916+2.945
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Cassava Sciences Inc.

3.1. Institutions holding Cassava Sciences Inc

Institutions are holding 32.709% of the shares of Cassava Sciences Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31BlackRock Inc7.0270.001730374151984316.9895
2023-12-31Vanguard Group Inc5.37790.00112324626560602.4712
2023-12-31State Street Corporation2.47460.00121069649440594.296
2023-12-31Geode Capital Management, LLC2.0220.0021873996437465.269
2023-12-31Gallacher Capital Management LLC1.34557.299558160637820.6545
2023-12-31Morgan Stanley - Brokerage Accounts1.25220.001154127310803224.9358
2023-12-31COWEN AND COMPANY, LLC1.15670.73825000005000000
2023-12-31Northern Trust Corp0.89690.0016387666140323.7555
2023-12-31JANE STREET GROUP, LLC0.86570.00223742063606862667.7959
2023-12-31Goldman Sachs Group Inc0.7480.0007323318270115507.7063
2023-12-31Charles Schwab Investment Management Inc0.71450.001830883641151.3504
2023-12-31Nuveen Asset Management, LLC0.64440.0022785348766345.9279
2023-12-31Bank of America Corp0.54120.0005233941-387862-62.377
2023-12-31NORGES BANK0.50090.0009216503-113539-34.4014
2023-12-31Clear Creek Investment Mgmt LLC0.31140.48111346053026529.0061
2023-12-31Bank of New York Mellon Corp0.30630.0006132418-2686-1.9881
2023-12-31Advisor Group Holdings, Inc.0.27360.0047118244-10400-8.0843
2023-12-31Susquehanna Portfolio Strategies LLC0.25540.04421104121104120
2023-12-31Barclays PLC0.24430.000910559078888295.4385
2023-12-31Jefferies Financial Group Inc0.22570.014397562-139463-58.8389
Total 27.18428.600411750400+1256336+10.7%

3.2. Funds holding Cassava Sciences Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-02-29Vanguard Total Stock Mkt Idx Inv2.86380.0018123788000
2024-02-29iShares Russell 2000 ETF2.23850.0357967580-158-0.0163
2024-02-29Vanguard Institutional Extnd Mkt Idx Tr1.35090.0132583944-566-0.0968
2023-12-31Fidelity Small Cap Index0.9160.035139592950731.2979
2024-02-29iShares Russell 2000 Growth ETF0.81080.0709350482-408-0.1163
2024-02-29State St Russell Sm/Mid Cp® Indx NL Cl C0.55790.013324116588003.7871
2024-01-31Fidelity Extended Market Index0.5110.014822088222141.0125
2024-02-29Schwab US Small-Cap ETF™0.4330.026118715100
2024-02-29SPDR® S&P Pharmaceuticals ETF0.43161.913718657500
2024-02-29State St Russell Sm Cap® Indx SL Cl I0.33920.035714662000
2024-02-29Vanguard Russell 2000 ETF0.33480.0349144738113928.5432
2024-02-29Vanguard Health Care ETF0.31860.015213770228622.1225
2023-12-31NT R2000 Growth Index Fund - NL0.27580.0726119218-1136-0.9439
2023-12-31NT R2000 Index Fund - NL0.26450.0355114343-892-0.7741
2024-02-29iShares US Pharmaceuticals ETF0.25960.383811221700
2023-09-30BlackRock Extended Mkt Composite0.2230.0114963766960.7274
2024-02-29Schwab Small Cap Index0.21120.035591298-517-0.5631
2023-12-31NT R2000 Index Fund - DC - NL - 20.20830.035590046-1052-1.1548
2023-12-31NT R2000 Growth Index Fund - L0.20650.07248928046755.5257
2023-12-31Northern Trust Russell 2000 Growth Index0.20650.07278928046755.5257
Total 12.96152.92985602706+35658+0.6%

3.3. Insider Transactions

Insiders are holding 7.171% of the shares of Cassava Sciences Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2023-08-23Sanford RobertsonBUY4200012.46
2023-08-21Richard BarryBUY266812
2023-08-21Richard BarryBUY266812

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Cassava Sciences Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.408-0.521+28%-0.152-63%0.136-400%0.052-892%
Book Value Per Share--3.1793.908-19%5.097-38%3.327-4%1.955+63%
Current Ratio--9.13210.382-12%27.027-66%28.412-68%24.248-62%
Debt To Asset Ratio--0.0940.087+7%0.035+165%0.049+92%0.056+66%
Debt To Equity Ratio--0.1030.096+7%0.037+182%0.052+99%0.061+70%
Dividend Per Share----0%-0%-0%-0%
Eps---0.484-0.562+16%-0.441-9%-0.251-48%-0.160-67%
Free Cash Flow Per Share---0.517-0.477-8%-0.464-10%-0.258-50%-0.154-70%
Free Cash Flow To Equity Per Share---0.491-0.462-6%-0.187-62%-0.106-78%-0.063-87%
Gross Profit Margin--1.0171.004+1%1.000+2%1.045-3%1.022-1%
Intrinsic Value_10Y_max---13.466--------
Intrinsic Value_10Y_min---34.906--------
Intrinsic Value_1Y_max---0.725--------
Intrinsic Value_1Y_min---1.983--------
Intrinsic Value_3Y_max---2.654--------
Intrinsic Value_3Y_min---7.304--------
Intrinsic Value_5Y_max---5.156--------
Intrinsic Value_5Y_min---14.063--------
Market Cap896917892.000-9%973462958.000949137195.500+3%1477060299.000-34%1070333550.000-9%594089177.500+64%
Net Profit Margin---8.909-2.227-75%2407.083-100%4023.971-100%2011.986-100%
Operating Margin---9.706-2.426-75%2961.944-100%4281.154-100%2140.577-100%
Operating Ratio--9.7062.426+300%-2961.944+30618%-4202.904+43403%-2101.452+21752%
Pb Ratio6.525-9%7.0815.686+25%6.765+5%7.164-1%6.861+3%
Pe Ratio-10.719+8%-11.634-9.861-15%-19.413+67%-40.007+244%-25.379+118%
Price Per Share20.740-9%22.51021.948+3%34.155-34%24.750-9%13.738+64%
Price To Free Cash Flow Ratio-10.029+8%-10.885-12.532+15%-19.015+75%-46.684+329%-30.844+183%
Price To Total Gains Ratio-50.826+8%-55.163-43.047-22%-52.035-6%-215.120+290%-119.902+117%
Quick Ratio--8.6019.954-14%25.746-67%27.811-69%24.104-64%
Return On Assets---0.138-0.130-6%-0.079-42%-0.068-51%-0.102-26%
Return On Equity---0.152-0.143-6%-0.082-46%-0.072-53%-0.109-28%
Total Gains Per Share---0.408-0.521+28%-0.152-63%0.136-400%0.052-892%
Usd Book Value--137468000.000168985250.000-19%220430500.000-38%143895950.000-4%84551850.000+63%
Usd Book Value Change Per Share---0.408-0.521+28%-0.152-63%0.136-400%0.052-892%
Usd Book Value Per Share--3.1793.908-19%5.097-38%3.327-4%1.955+63%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.484-0.562+16%-0.441-9%-0.251-48%-0.160-67%
Usd Free Cash Flow---22357000.000-20609750.000-8%-20056500.000-10%-11163100.000-50%-6679600.000-70%
Usd Free Cash Flow Per Share---0.517-0.477-8%-0.464-10%-0.258-50%-0.154-70%
Usd Free Cash Flow To Equity Per Share---0.491-0.462-6%-0.187-62%-0.106-78%-0.063-87%
Usd Market Cap896917892.000-9%973462958.000949137195.500+3%1477060299.000-34%1070333550.000-9%594089177.500+64%
Usd Price Per Share20.740-9%22.51021.948+3%34.155-34%24.750-9%13.738+64%
Usd Profit---20919000.000-23646250.000+13%-18039500.000-14%-10504650.000-50%-6748525.000-68%
Usd Revenue--2348000.000587000.000+300%-450.000+100%117300.000+1902%58650.000+3903%
Usd Total Gains Per Share---0.408-0.521+28%-0.152-63%0.136-400%0.052-892%
 EOD+3 -5MRQTTM+13 -21YOY+3 -315Y+4 -3010Y+8 -26

4.2. Fundamental Score

Let's check the fundamental score of Cassava Sciences Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-10.719
Price to Book Ratio (EOD)Between0-16.525
Net Profit Margin (MRQ)Greater than0-8.909
Operating Margin (MRQ)Greater than0-9.706
Quick Ratio (MRQ)Greater than18.601
Current Ratio (MRQ)Greater than19.132
Debt to Asset Ratio (MRQ)Less than10.094
Debt to Equity Ratio (MRQ)Less than10.103
Return on Equity (MRQ)Greater than0.15-0.152
Return on Assets (MRQ)Greater than0.05-0.138
Total4/10 (40.0%)

4.3. Technical Score

Let's check the technical score of Cassava Sciences Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5046.999
Ma 20Greater thanMa 5021.518
Ma 50Greater thanMa 10021.576
Ma 100Greater thanMa 20023.179
OpenGreater thanClose20.680
Total1/5 (20.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-12-312023-03-312023-06-302023-09-302023-12-31
Gross Profit  -3910-3910-391-1-3922,3841,992
Income Tax Expense  -1,803-829-2,63243-2,589192-2,39710,0157,618



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets151,663
Total Liabilities14,195
Total Stockholder Equity137,468
 As reported
Total Liabilities 14,195
Total Stockholder Equity+ 137,468
Total Assets = 151,663

Assets

Total Assets151,663
Total Current Assets129,633
Long-term Assets22,030
Total Current Assets
Cash And Cash Equivalents 121,136
Net Receivables 962
Other Current Assets 7,535
Total Current Assets  (as reported)129,633
Total Current Assets  (calculated)129,633
+/-0
Long-term Assets
Property Plant Equipment 21,854
Intangible Assets 176
Long-term Assets  (as reported)22,030
Long-term Assets  (calculated)22,030
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities14,195
Long-term Liabilities0
Total Stockholder Equity137,468
Total Current Liabilities
Accounts payable 10,573
Other Current Liabilities 3,622
Total Current Liabilities  (as reported)14,195
Total Current Liabilities  (calculated)14,195
+/-0
Long-term Liabilities
Long-term Liabilities  (as reported)0
Long-term Liabilities  (calculated)0
+/-0
Total Stockholder Equity
Common Stock42
Retained Earnings -380,769
Other Stockholders Equity 518,195
Total Stockholder Equity (as reported)137,468
Total Stockholder Equity (calculated)137,468
+/-0
Other
Capital Stock42
Cash and Short Term Investments 121,136
Common Stock Shares Outstanding 42,188
Liabilities and Stockholders Equity 151,663
Net Debt -121,136
Net Invested Capital 137,468
Net Working Capital 115,438
Property Plant and Equipment Gross 24,138



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-302004-06-302004-03-312003-12-312003-09-302003-06-302003-03-312002-12-312002-09-302002-06-302002-03-312001-12-312001-09-302001-06-302001-03-312000-12-312000-09-302000-06-302000-03-31
> Total Assets 
22,865
21,139
82,841
81,147
81,147
74,504
71,470
68,136
64,032
60,640
56,691
53,325
48,028
44,531
86,638
80,513
72,425
62,904
55,802
101,192
92,772
83,190
73,774
215,795
215,778
213,243
218,286
208,456
212,245
208,633
208,810
207,625
192,497
179,122
195,497
193,436
189,733
186,316
182,732
182,005
178,597
182,084
180,794
99,195
101,226
102,593
100,592
98,963
96,810
94,440
93,259
56,859
54,870
53,200
51,756
50,103
47,319
45,391
43,591
40,906
39,635
37,756
35,653
31,918
28,626
24,940
22,482
19,302
17,604
14,269
12,377
10,831
11,058
9,833
20,836
20,139
19,523
18,805
18,375
23,486
25,977
25,498
25,399
94,300
284,050
281,305
274,249
266,782
244,191
227,381
207,286
234,834
218,111
197,248
172,529
151,663
151,663172,529197,248218,111234,834207,286227,381244,191266,782274,249281,305284,05094,30025,39925,49825,97723,48618,37518,80519,52320,13920,8369,83311,05810,83112,37714,26917,60419,30222,48224,94028,62631,91835,65337,75639,63540,90643,59145,39147,31950,10351,75653,20054,87056,85993,25994,44096,81098,963100,592102,593101,22699,195180,794182,084178,597182,005182,732186,316189,733193,436195,497179,122192,497207,625208,810208,633212,245208,456218,286213,243215,778215,79573,77483,19092,772101,19255,80262,90472,42580,51386,63844,53148,02853,32556,69160,64064,03268,13671,47074,50481,14781,14782,84121,13922,865
   > Total Current Assets 
22,283
20,073
82,576
79,773
79,773
71,964
68,963
65,714
61,693
58,389
54,530
51,247
46,036
42,625
84,816
78,750
70,540
61,038
53,974
99,656
91,293
81,685
72,087
214,164
214,147
211,693
216,859
207,114
210,254
206,659
206,407
205,374
190,363
177,105
193,598
190,636
187,605
184,255
180,981
178,471
177,714
181,260
180,028
98,484
100,557
101,964
100,084
98,489
96,371
94,037
92,907
56,507
54,518
52,848
51,416
50,103
47,243
45,307
43,510
40,829
39,367
37,502
35,413
31,691
28,413
24,741
22,220
19,070
17,390
14,079
12,204
10,663
10,889
9,699
20,720
20,040
19,265
18,583
18,189
23,349
25,877
25,440
25,071
93,994
283,766
279,558
251,915
244,482
222,200
204,201
183,272
211,226
194,999
174,533
150,184
129,633
129,633150,184174,533194,999211,226183,272204,201222,200244,482251,915279,558283,76693,99425,07125,44025,87723,34918,18918,58319,26520,04020,7209,69910,88910,66312,20414,07917,39019,07022,22024,74128,41331,69135,41337,50239,36740,82943,51045,30747,24350,10351,41652,84854,51856,50792,90794,03796,37198,489100,084101,964100,55798,484180,028181,260177,714178,471180,981184,255187,605190,636193,598177,105190,363205,374206,407206,659210,254207,114216,859211,693214,147214,16472,08781,68591,29399,65653,97461,03870,54078,75084,81642,62546,03651,24754,53058,38961,69365,71468,96371,96479,77379,77382,57620,07322,283
       Cash And Cash Equivalents 
22,179
20,021
81,997
78,927
78,927
71,642
68,442
65,274
61,359
57,806
53,893
50,091
45,664
42,546
46,900
12,027
7,181
3,172
1,750
1,379
107
2,512
1,421
95,651
67,825
51,109
31,558
16,386
61,816
49,191
40,814
86,567
130,807
125,425
143,950
153,158
172,790
145,200
29,169
35,794
50,657
66,773
106,292
4,798
54,894
62,830
71,709
73,144
73,779
79,020
88,240
56,254
51,591
51,545
51,027
49,838
47,102
44,825
42,052
40,590
39,248
36,352
33,993
31,299
26,614
24,626
21,764
18,714
17,264
14,067
11,916
10,479
10,734
9,608
20,444
19,807
19,125
18,534
17,804
23,081
25,600
25,254
24,074
93,506
282,192
278,254
241,524
233,437
209,693
197,232
174,662
201,015
187,467
168,438
142,350
121,136
121,136142,350168,438187,467201,015174,662197,232209,693233,437241,524278,254282,19293,50624,07425,25425,60023,08117,80418,53419,12519,80720,4449,60810,73410,47911,91614,06717,26418,71421,76424,62626,61431,29933,99336,35239,24840,59042,05244,82547,10249,83851,02751,54551,59156,25488,24079,02073,77973,14471,70962,83054,8944,798106,29266,77350,65735,79429,169145,200172,790153,158143,950125,425130,80786,56740,81449,19161,81616,38631,55851,10967,82595,6511,4212,5121071,3791,7503,1727,18112,02746,90042,54645,66450,09153,89357,80661,35965,27468,44271,64278,92778,92781,99720,02122,179
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
36,290
55
63,004
57,820
51,809
98,018
0
79,138
70,126
117,001
141,963
154,232
182,360
188,014
148,144
157,136
165,113
118,504
59,245
51,648
49,240
36,937
12,784
37,017
148,306
139,965
124,876
109,469
73,450
86,428
43,583
38,211
27,651
24,987
22,117
14,922
4,289
6,899
2,800
1,300
1,300
1,250
1,250
250
1,100
0
1,999
950
900
0
1,500
0
550
2,099
2,099
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000000002,0992,09955001,50009009501,99901,1002501,2501,2501,3001,3002,8006,8994,28914,92222,11724,98727,65138,21143,58386,42873,450109,469124,876139,965148,30637,01712,78436,93749,24051,64859,245118,504165,113157,136148,144188,014182,360154,232141,963117,00170,12679,138098,01851,80957,82063,0045536,29000000000000000
       Net Receivables 
32
6
8
445
445
255
200
117
96
83
74
55
46
38
0
65,402
65,402
0
-415
98,018
91,034
0
0
889
4,234
6,305
2,596
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
7,114
1,996
908
231
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
86
0
1,271
0
0
0
0
0
0
0
0
1,328
1,285
962
9621,2851,328000000001,271086000000000000000000000000000000000002319081,9967,11400000000000000002,5966,3054,2348890091,03498,018-415065,40265,40203846557483961172002554454458632
       Other Current Assets 
72
46
571
0
401
67
321
323
238
500
563
1,101
326
41
1,626
1,321
355
46
415
259
152
35
540
623
125
47
345
2,714
294
332
480
303
311
32
408
541
2,031
2,038
3,506
2,712
2,181
5,018
286
144
84
101,056
493
358
475
95
378
253
127
3
389
265
141
482
358
239
119
200
520
392
299
115
456
356
126
12
288
184
155
91
276
233
140
49
385
268
277
186
225
488
1,574
1,304
10,391
11,045
69
6,969
8,610
10,211
7,532
6,095
7,834
7,535
7,5357,8346,0957,53210,2118,6106,9696911,04510,3911,3041,574488225186277268385491402332769115518428812126356456115299392520200119239358482141265389312725337895475358493101,056841442865,0182,1812,7123,5062,0382,031541408323113034803322942,7143454712562354035152259415463551,3211,626413261,1015635002383233216740105714672
   > Long-term Assets 
582
1,066
265
0
1,374
2,540
2,506
2,421
2,339
2,251
2,161
2,078
1,992
1,906
1,822
1,763
1,885
1,866
1,828
1,536
1,479
1,505
1,687
1,631
1,631
1,550
1,427
1,342
1,991
1,974
2,403
2,251
2,134
2,017
1,899
2,800
2,128
2,061
1,751
3,534
883
824
766
711
669
629
508
474
439
403
352
352
352
352
340
7,504
76
84
81
77
268
254
240
227
213
199
262
232
214
190
173
168
169
134
116
99
258
222
186
137
100
58
330
306
284
1,747
22,334
22,300
21,991
23,180
24,014
23,608
23,112
22,715
22,345
22,030
22,03022,34522,71523,11223,60824,01423,18021,99122,30022,3341,7472843063305810013718622225899116134169168173190214232262199213227240254268778184767,5043403523523523524034394745086296697117668248833,5341,7512,0612,1282,8001,8992,0172,1342,2512,4031,9741,9911,3421,4271,5501,6311,6311,6871,5051,4791,5361,8281,8661,8851,7631,8221,9061,9922,0782,1612,2512,3392,4212,5062,5401,37402651,066582
       Property Plant Equipment 
122
124
265
1,299
1,299
2,465
2,431
2,346
2,264
2,176
2,086
2,003
1,917
1,831
1,747
1,688
1,810
1,791
1,753
1,461
1,404
1,430
1,612
1,556
1,556
1,475
1,352
1,267
1,223
1,206
1,549
1,607
1,490
1,373
1,256
774
708
641
578
517
457
398
340
285
232
192
157
122
87
52
352
0
0
0
0
0
76
72
69
100
256
242
228
200
201
187
250
300
214
190
173
200
139
122
104
100
246
210
174
137
100
58
330
306
284
327
20,926
20,826
21,051
22,321
23,274
22,986
22,609
22,328
22,077
21,854
21,85422,07722,32822,60922,98623,27422,32121,05120,82620,926327284306330581001371742102461001041221392001731902143002501872012002282422561006972760000035252871221571922322853403984575175786417087741,2561,3731,4901,6071,5491,2061,2231,2671,3521,4751,5561,5561,6121,4301,4041,4611,7531,7911,8101,6881,7471,8311,9172,0032,0862,1762,2642,3462,4312,4651,2991,299265124122
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,209
1,075
940
859
740
622
503
387
268
176
1762683875036227408599401,0751,20900000000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Long-term Assets Other 
460
942
0
75
75
75
75
75
75
75
75
75
75
75
75
75
75
75
75
75
75
75
75
75
75
75
75
75
768
768
854
644
644
644
643
2,026
1,420
1,420
1,173
3,017
426
426
426
426
437
437
351
352
352
351
352
352
352
352
340
7,504
0
12
12
-23
12
12
12
27
12
12
12
-68
232
0
0
-32
30
12
12
-1
12
12
12
90
67
45
0
295
274
1,420
199
399
188
166
144
0
0
0
0
0
000001441661883991991,4202742950456790121212-1121230-3200232-6812121227121212-23121207,5043403523523523523513523523514374374264264264263,0171,1731,4201,4202,026643644644644854768768757575757575757575757575757575757575757575757575750942460
> Total Liabilities 
488
720
1,352
2,452
2,452
1,487
1,386
2,519
1,993
2,003
1,460
3,101
2,319
2,395
4,018
3,951
5,820
5,161
7,127
7,796
8,221
8,253
7,635
152,435
149,498
144,191
136,950
130,541
121,120
115,122
109,762
103,711
100,174
95,735
92,983
89,150
85,557
80,463
76,671
73,753
68,647
71,398
69,603
66,262
62,829
59,562
57,106
54,570
51,512
48,271
46,927
43,723
41,460
39,025
37,504
1,801
1,618
1,739
2,383
850
1,200
1,813
2,586
2,551
3,344
1,953
2,167
665
883
999
1,010
1,132
758
1,287
862
511
970
982
930
1,387
1,145
1,314
1,426
2,100
2,863
4,825
6,684
12,867
7,097
9,011
8,567
7,295
14,106
17,895
17,414
14,195
14,19517,41417,89514,1067,2958,5679,0117,09712,8676,6844,8252,8632,1001,4261,3141,1451,3879309829705118621,2877581,1321,0109998836652,1671,9533,3442,5512,5861,8131,2008502,3831,7391,6181,80137,50439,02541,46043,72346,92748,27151,51254,57057,10659,56262,82966,26269,60371,39868,64773,75376,67180,46385,55789,15092,98395,735100,174103,711109,762115,122121,120130,541136,950144,191149,498152,4357,6358,2538,2217,7967,1275,1615,8203,9514,0182,3952,3193,1011,4602,0031,9932,5191,3861,4872,4522,4521,352720488
   > Total Current Liabilities 
488
720
1,352
2,452
2,452
1,487
1,386
2,519
1,993
2,003
1,460
3,101
2,319
2,395
4,018
3,951
5,820
5,161
7,127
7,796
8,221
8,253
7,635
32,347
35,960
37,203
36,512
36,654
33,023
33,575
34,762
20,657
20,706
19,854
20,683
20,114
19,577
18,069
18,110
18,511
12,692
13,760
14,689
14,071
13,361
12,818
13,085
13,272
12,938
12,421
13,800
9,999
9,694
9,218
9,655
1,801
1,618
1,739
2,383
850
1,200
1,813
2,586
2,551
3,344
1,953
2,167
665
883
999
1,010
1,132
758
1,287
862
511
902
937
907
1,387
1,145
1,314
1,168
1,865
2,650
4,637
6,326
12,534
6,789
8,722
8,308
7,063
13,909
17,895
17,414
14,195
14,19517,41417,89513,9097,0638,3088,7226,78912,5346,3264,6372,6501,8651,1681,3141,1451,3879079379025118621,2877581,1321,0109998836652,1671,9533,3442,5512,5861,8131,2008502,3831,7391,6181,8019,6559,2189,6949,99913,80012,42112,93813,27213,08512,81813,36114,07114,68913,76012,69218,51118,11018,06919,57720,11420,68319,85420,70620,65734,76233,57533,02336,65436,51237,20335,96032,3477,6358,2538,2217,7967,1275,1615,8203,9514,0182,3952,3193,1011,4602,0031,9932,5191,3861,4872,4522,4521,352720488
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
6,295
6,690
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-7,820
0
0
576
0
0
0
0
793
-929
0
0
-742
-41,760
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
90
90
90
90
67
45
58
58
84
93
95
97
99
100
102
104
0
0
0
0
00001041021009997959384585845679090909000000000000000000000-41,760-74200-929793000057600-7,820000000000000006,6906,29500000000000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
90
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000900000000000000000000000000000000000000000000000000000000000000000000000000000
       Accounts payable 
488
720
1,352
0
2,313
1,343
1,231
2,170
1,446
1,406
1,072
2,648
1,728
1,731
3,537
3,441
5,105
817
831
877
904
1,006
564
998
820
596
438
985
840
2,220
3,008
3,624
2,962
3,206
3,485
2,216
1,685
975
1,005
1,317
485
625
715
1,107
436
604
556
464
502
501
507
1,290
366
435
1,273
1,086
729
692
822
198
462
465
898
1,928
1,043
1,019
1,827
330
573
658
712
424
421
962
549
294
495
594
340
453
608
416
465
911
864
1,912
2,345
7,126
3,332
4,758
3,534
4,017
8,242
10,338
9,492
10,573
10,5739,49210,3388,2424,0173,5344,7583,3327,1262,3451,9128649114654166084533405944952945499624214247126585733301,8271,0191,0431,9288984654621988226927291,0861,2734353661,2905075015024645566044361,1077156254851,3171,0059751,6852,2163,4853,2062,9623,6243,0082,2208409854385968209985641,0069048778318175,1053,4413,5371,7311,7282,6481,0721,4061,4462,1701,2311,3432,31301,352720488
       Other Current Liabilities 
0
0
0
0
139
144
155
349
547
597
388
453
591
664
481
510
715
4,344
6,296
6,919
7,317
7,247
7,071
5,149
8,940
10,407
3,579
2,779
5,983
5,155
5,554
2,685
3,396
2,300
2,850
3,550
3,544
2,746
2,757
2,846
2,110
2,238
10,897
2,067
2,028
741
1,632
1,911
1,539
1,023
1,603
1,806
1,496
951
1,292
1,356
889
1,047
1,561
652
738
1,348
1,688
623
2,301
934
340
335
310
341
298
708
337
325
313
217
12
14
7
9
11
14
7
94
50
50
509
631
3,358
3,864
4,672
2,942
5,667
7,557
7,922
3,622
3,6227,9227,5575,6672,9424,6723,8643,358631509505094714119714122173133253377082983413103353409342,3016231,6881,3487386521,5611,0478891,3561,2929511,4961,8061,6031,0231,5391,9111,6327412,0282,06710,8972,2382,1102,8462,7572,7463,5443,5502,8502,3003,3962,6855,5545,1555,9832,7793,57910,4078,9405,1497,0717,2477,3176,9196,2964,3447155104816645914533885975473491551441390000
   > Long-term Liabilities 
488
720
1,352
0
2,313
1,343
1,231
2,170
1,446
1,406
1,072
2,648
1,728
1,731
3,537
3,441
5,105
817
831
877
904
1,006
564
120,088
113,538
106,988
100,438
93,887
88,097
81,547
75,000
83,054
79,468
75,881
72,300
69,036
65,980
62,394
58,561
55,242
55,955
57,638
54,914
52,191
49,468
46,744
44,021
41,298
38,574
35,850
33,127
33,724
31,766
29,807
27,849
445
428
360
822
173
255
465
898
1,034
1,043
378
1,083
303
573
658
712
424
421
962
549
294
68
45
23
543
675
461
258
235
213
188
358
333
308
289
259
232
197
0
0
0
0001972322592893083333581882132352584616755432345682945499624214247126585733031,0833781,0431,03489846525517382236042844527,84929,80731,76633,72433,12735,85038,57441,29844,02146,74449,46852,19154,91457,63855,95555,24258,56162,39465,98069,03672,30075,88179,46883,05475,00081,54788,09793,887100,438106,988113,538120,0885641,0069048778318175,1053,4413,5371,7311,7282,6481,0721,4061,4462,1701,2311,3432,31301,352720488
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
194
194
194
201
197
197
0
0
0
0
000019719720119419419400000000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
46,312
43,587
41,298
38,574
35,850
33,127
33,724
31,766
29,807
27,849
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000000000000000000000027,84929,80731,76633,72433,12735,85038,57441,29843,58746,312000000000000000000000000000000000000000000000
> Total Stockholder Equity
22,377
20,418
81,489
0
78,695
73,017
70,084
65,616
62,038
58,636
55,231
50,224
45,709
42,136
82,620
76,562
66,605
57,743
48,675
93,396
84,551
74,937
66,139
63,360
66,280
69,052
81,336
77,915
91,125
93,511
99,048
103,914
92,323
83,387
102,514
104,286
104,176
105,853
106,061
108,252
109,950
110,686
111,191
32,933
38,397
43,031
43,486
44,393
45,298
46,169
46,332
13,136
13,410
14,175
14,252
48,302
45,701
43,652
41,208
40,056
38,435
35,943
33,067
29,367
25,282
22,987
20,315
18,637
16,721
13,270
11,367
9,699
10,300
8,546
19,974
19,628
18,553
17,823
17,445
22,099
24,832
24,184
23,973
92,200
281,187
276,480
267,565
253,915
237,094
218,370
198,719
227,539
204,005
179,353
155,115
137,468
137,468155,115179,353204,005227,539198,719218,370237,094253,915267,565276,480281,18792,20023,97324,18424,83222,09917,44517,82318,55319,62819,9748,54610,3009,69911,36713,27016,72118,63720,31522,98725,28229,36733,06735,94338,43540,05641,20843,65245,70148,30214,25214,17513,41013,13646,33246,16945,29844,39343,48643,03138,39732,933111,191110,686109,950108,252106,061105,853104,176104,286102,51483,38792,323103,91499,04893,51191,12577,91581,33669,05266,28063,36066,13974,93784,55193,39648,67557,74366,60576,56282,62042,13645,70950,22455,23158,63662,03865,61670,08473,01778,695081,48920,41822,377
   Common Stock
10
10
27
0
27
27
27
27
27
27
27
27
27
27
35
35
35
36
36
44
44
44
44
44
44
44
44
44
44
44
44
44
42
41
42
42
42
42
42
42
43
43
43
43
44
45
45
45
45
45
45
45
45
45
151,373
45
153,257
154,454
45
46
157,510
46
46
46
46
162,435
163,280
46
46
7
7
7
7
7
17
17
183,868
17
17
190,686
25
25
26
267,121
459,634
460,052
460,699
461,221
40
462,531
463,137
511,091
511,828
513,552
514,965
42
42514,965513,552511,828511,091463,137462,53140461,221460,699460,052459,634267,121262525190,6861717183,8681717777774646163,280162,43546464646157,5104645154,454153,25745151,37345454545454545454544434343434242424242424142444444444444444444444444443636353535272727272727272727270271010
   Retained Earnings Total Equity00-334,199-307,8230-264,418-244,161-224,833-207,306-193,134-183,572-178,447-174,9210-170,873-169,737-168,587-167,071-166,374-165,315-163,956-163,279-162,012-159,559-157,399-154,982-152,391-148,231-145,488-142,966-139,448-136,433-130,638-126,121-122,450-119,076-116,493-114,337-110,802-107,557-104,107-137,122-136,360-136,059-135,651-133,857-132,306-132,175-132,205-131,814-130,999000000000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 
-8,572
-7,099
-6,914
-49
-5,146
-2,893
-2,406
-1,914
-1,480
-1,279
-1,388
-426
-318
-68
-1
43
157
-267
-122
-544
-823
-472
-512
-479
-815
-1,130
-291
-372
103
-177
354
584
905
465
-183
325
195
99
-31
347
664
473
693
525
468
394
121
128
96
43
2
4
1
1
1
1
1
0
1
1
1
1
1
-700
-700
0
1
-700
-700
0
0
-800
0
0
0
-900
-900
0
0
-900
-900
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000-900-90000-900-900000-80000-700-70010-700-70011111011111424396128121394468525693473664347-3199195325-183465905584354-177103-372-291-1,130-815-479-512-472-823-544-122-26715743-1-68-318-426-1,388-1,279-1,480-1,914-2,406-2,893-5,146-49-6,914-7,099-8,572
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
173,591
175,134
176,425
177,332
178,387
180,142
148,738
149,423
150,489
151,328
152,363
153,212
154,409
155,499
156,502
157,464
158,346
159,141
159,959
161,669
162,389
163,234
164,079
164,906
165,654
166,342
167,091
169,852
170,551
183,236
183,567
183,851
184,180
184,499
190,664
194,544
195,032
0
267,086
459,594
460,012
460,659
461,181
461,887
462,491
463,097
0
511,786
513,510
0
0
00513,510511,7860463,097462,491461,887461,181460,659460,012459,594267,0860195,032194,544190,664184,499184,180183,851183,567183,236170,551169,852167,091166,342165,654164,906164,079163,234162,389161,669159,959159,141158,346157,464156,502155,499154,409153,212152,363151,328150,489149,423148,738180,142178,387177,332176,425175,134173,591000000000000000000000000000000000000000000000
   Treasury Stock000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
17,698
17,780
100,982
0
101,085
100,684
101,121
102,557
103,005
103,317
102,962
103,438
103,540
104,312
150,758
151,726
151,932
152,136
152,298
206,656
206,120
206,968
206,656
207,558
209,053
210,458
213,635
216,236
217,557
217,759
220,123
220,999
214,143
213,465
217,401
218,902
219,865
221,672
223,322
226,592
227,496
229,563
230,569
161,482
167,684
173,591
175,134
177,761
177,332
178,387
180,142
149,371
149,423
150,489
151,328
152,363
153,212
154,409
155,499
157,103
157,464
158,346
159,141
160,659
161,669
162,389
163,234
164,779
164,906
165,654
166,342
167,891
169,852
170,551
183,236
184,467
183,851
184,180
184,499
191,564
194,544
195,032
196,250
267,086
459,594
460,012
460,659
461,181
461,887
462,491
463,097
511,049
0
-953
514,923
518,195
518,195514,923-9530511,049463,097462,491461,887461,181460,659460,012459,594267,086196,250195,032194,544191,564184,499184,180183,851184,467183,236170,551169,852167,891166,342165,654164,906164,779163,234162,389161,669160,659159,141158,346157,464157,103155,499154,409153,212152,363151,328150,489149,423149,371180,142178,387177,332177,761175,134173,591167,684161,482230,569229,563227,496226,592223,322221,672219,865218,902217,401213,465214,143220,999220,123217,759217,557216,236213,635210,458209,053207,558206,656206,968206,120206,656152,298152,136151,932151,726150,758104,312103,540103,438102,962103,317103,005102,557101,121100,684101,0850100,98217,78017,698



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue0
Cost of Revenue-1,530
Gross Profit-1,530-1,530
 
Operating Income (+$)
Gross Profit-1,530
Operating Expense-104,427
Operating Income-105,957-105,957
 
Operating Expense (+$)
Research Development89,423
Selling General Administrative16,534
Selling And Marketing Expenses1,530
Operating Expense104,427107,487
 
Net Interest Income (+$)
Interest Income7,833
Interest Expense-0
Other Finance Cost-0
Net Interest Income7,833
 
Pretax Income (+$)
Operating Income-105,957
Net Interest Income7,833
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-97,217-114,697
EBIT - interestExpense = -105,957
-97,217
-97,217
Interest Expense0
Earnings Before Interest and Taxes (EBIT)-105,957-97,217
Earnings Before Interest and Taxes (EBITDA)-104,427
 
After tax Income (+$)
Income Before Tax-97,217
Tax Provision-0
Net Income From Continuing Ops-97,217-97,217
Net Income-97,217
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses105,957
Total Other Income/Expenses Net8,740-7,833
 

Technical Analysis of Cassava Sciences Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Cassava Sciences Inc. The general trend of Cassava Sciences Inc is BEARISH with 28.6% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Cassava Sciences Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-28.6%) Bearish trend (28.6%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Cassava Sciences Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 26.19 < 26.68 < 27.18.

The bearish price targets are: 19.46 > 19.44 > 18.18.

Tweet this
Cassava Sciences Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Cassava Sciences Inc. The current mas is .

The long score for the Moving Averages is 5/14.
The longshort score for the Moving Averages is -4/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Cassava Sciences Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Cassava Sciences Inc. The current macd is -0.2460081.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Cassava Sciences Inc price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Cassava Sciences Inc. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Cassava Sciences Inc price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Cassava Sciences Inc Daily Moving Average Convergence/Divergence (MACD) ChartCassava Sciences Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Cassava Sciences Inc. The current adx is 13.79.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -1/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Cassava Sciences Inc shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Cassava Sciences Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Cassava Sciences Inc. The current sar is 24.99.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Cassava Sciences Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Cassava Sciences Inc. The current rsi is 47.00. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
Cassava Sciences Inc Daily Relative Strength Index (RSI) ChartCassava Sciences Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Cassava Sciences Inc. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Cassava Sciences Inc price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Cassava Sciences Inc Daily Stochastic Oscillator ChartCassava Sciences Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Cassava Sciences Inc. The current cci is -43.08555532.

Cassava Sciences Inc Daily Commodity Channel Index (CCI) ChartCassava Sciences Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Cassava Sciences Inc. The current cmo is -7.62772835.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Cassava Sciences Inc Daily Chande Momentum Oscillator (CMO) ChartCassava Sciences Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Cassava Sciences Inc. The current willr is -81.97688069.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Cassava Sciences Inc Daily Williams %R ChartCassava Sciences Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Cassava Sciences Inc.

Cassava Sciences Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Cassava Sciences Inc. The current atr is 1.48291427.

Cassava Sciences Inc Daily Average True Range (ATR) ChartCassava Sciences Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Cassava Sciences Inc. The current obv is 15,254,476.

Cassava Sciences Inc Daily On-Balance Volume (OBV) ChartCassava Sciences Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Cassava Sciences Inc. The current mfi is 52.50.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Cassava Sciences Inc Daily Money Flow Index (MFI) ChartCassava Sciences Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Cassava Sciences Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-04CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-05STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-07CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-11ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-12STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-14STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-15STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-19RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2023-12-21SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-12-27WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-03STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-04WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-08CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-09CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-10CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-11SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-12MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-01-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-19WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-22CCI LONG ENTRY SHORT CLOSE100 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-24CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-25MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-26SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-31DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-02STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-07DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-09MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-13MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-15STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-16STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-20DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-28DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-03-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-06BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-07STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-12RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-14DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-15MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-19SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-03-21STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-22DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-01DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-02DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-03DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-05CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-08CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-09ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-10RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-11STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-12STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-15SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-17MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-19DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-22STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Cassava Sciences Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Cassava Sciences Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5046.999
Ma 20Greater thanMa 5021.518
Ma 50Greater thanMa 10021.576
Ma 100Greater thanMa 20023.179
OpenGreater thanClose20.680
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Cassava Sciences Inc with someone you think should read this too:
  • Are you bullish or bearish on Cassava Sciences Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Cassava Sciences Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Cassava Sciences Inc

I send you an email if I find something interesting about Cassava Sciences Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Cassava Sciences Inc.

Receive notifications about Cassava Sciences Inc in your mailbox!